1. New insights into the unfolded protein response in stem cells
   Yanzhou Yang et al, 2016, Oncotarget CrossRef
2. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling
   Neng Wang et al, 2014, Carcinogenesis CrossRef
3. Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy
   Alexander Kabakov et al, 2020, Cells CrossRef
4. Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential
   Amy S. Lee, 2014, Nature Reviews Cancer CrossRef
5. A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomib
   AZMI YERLIKAYA et al, 2016, Oncology Letters CrossRef
6. Effet de la radiothérapie sur les cellules souches cancéreuses de cancer du sein : résistance, reprogrammation et traitements
   J. Bailleul-Dubois et al, 2017, Oncologie CrossRef
7. Radiosensitization of calreticulin‐overexpressing human glioma cell line by the polyphenolic acetate 7, 8‐diacetoxy‐4‐methylcoumarin
   Amit Verma et al, 2022, Cancer Reports CrossRef
8. SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells
   Cristina Talarico et al, 2016, Oncotarget CrossRef
9. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells
   Babak Nami et al, 2016, Experimental and Toxicologic Pathology CrossRef
10. Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway
    Jie Xie et al, 2016, Biochemical and Biophysical Research Communications CrossRef
11. A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement
    Leo Rasche et al, 2016, Clinical Cancer Research CrossRef
12. Suppression of stress induction of the 78-kilodalton glucose regulated protein (GRP78) in cancer by IT-139, an anti-tumor ruthenium small molecule inhibitor
    Suzanne J. Bakewell et al, 2018, Oncotarget CrossRef
13. Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence
    Bashar Alhasan et al, 2023, Cancer and Metastasis Reviews CrossRef
14. Enterolactone: A novel radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis
    Bahareh Bigdeli et al, 2016, Toxicology and Applied Pharmacology CrossRef
15. The meta and bioinformatics analysis of GRP78 expression in gastric cancer
    Hua-Chuan Zheng et al, 2017, Oncotarget CrossRef
16. A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis
    Emrah Okur et al, 2019, Cell Biology and Toxicology CrossRef
17. MicroRNAs targeting prostate cancer stem cells
    Yu-Xiang Fang et al, 2015, Experimental Biology and Medicine CrossRef
18. Overexpression of molecular chaperons GRP78 and GRP94 in CD44hi/CD24lo breast cancer stem cells
    Babak Nami et al, 2016, BioImpacts CrossRef
19. Cancer Stem Cells as New Therapeutic Targets for Ovarian Cancer
    Y. Wang et al, 2016, Cancer Stem Cells CrossRef
20. Overexpression of Eukaryotic translation initiation factor 3D induces stem cell-like properties and metastasis in cervix cancer by activating FAK through inhibiting degradation of GRP78
    Yan Zhong et al, 2022, Bioengineered CrossRef
21. HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy
    Alexander E. Kabakov et al, 2021, Cells CrossRef
22. Effects of Prolonged GRP78 Haploinsufficiency on Organ Homeostasis, Behavior, Cancer and Chemotoxic Resistance in Aged Mice
    Amy S. Lee et al, 2017, Scientific Reports CrossRef
23. Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
    Kouji Banno et al, 2014, BioMed Research International CrossRef
24. GRP78 regulates sensitivity of human colorectal cancer cells to DNA targeting agents
    Nizar M. Mhaidat et al, 2016, Cytotechnology CrossRef